ADULT – Commentary| Volume 35, ISSUE 1, P86-87, March 2023

Commentary: Incursion of “Sarcopenia” Into Minimally Invasive Cardiac Surgery

  • Joon Bum Kim
    Address reprint requests to Joon Bum Kim, MD, PhD, Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, 388-1 Pungnap-dong Songpa-gu, Seoul 138-736, South Korea.
    Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
    Search for articles by this author
Published:December 05, 2021DOI:
      The study by Dr Lim et al indicates that the detrimental impacts of sarcopenia in cardiac surgery may be mitigated by minimally invasive techniques, which needs validation by further studies.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Seminars in Thoracic and Cardiovascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Rosenberg I.H.
        Sarcopenia: Origins and clinical relevance.
        J Nutr. 1997; 127: 990S-991S
        • Yoon Y.H.
        • Ko Y.
        • Kim K.W.
        • et al.
        Prognostic value of baseline sarcopenia on 1-year mortality in patients undergoing transcatheter aortic valve implantation.
        Am J Cardiol. 2021; 139: 79-86
        • Lee S.A.
        • Jang I.Y.
        • Park S.Y.
        • et al.
        Benefit of sarcopenia screening in older patients undergoing surgical aortic valve replacement.
        Ann Thorac Surg. 2021; (S0003-4975(21)01298-4)
        • Lim M.
        • Lee C.
        • Ju M.H.
        • et al.
        Impact of sarcopenia on outcomes of minimally invasive cardiac surgery.
        Semin Thorac Cardiovasc Surg. 2023; 35: 77-85

      Linked Article

      • Impact of Sarcopenia on Outcomes of Minimally Invasive Cardiac Surgery
        Seminars in Thoracic and Cardiovascular SurgeryVol. 35Issue 1
        • Preview
          Sarcopenia is an objective marker of poor outcome following cardiac surgery through median sternotomy. However, the clinical impact of sarcopenia after minimally invasive cardiac surgery (MICS) has not been well established. This study aimed to analyze the influence of sarcopenia on the early and late outcomes following MICS. We retrospectively examined 1248 patients who underwent MICS via right mini-thoracotomy or upper sternotomy between February 2009 and April 2020. Patients older than 65 years who underwent preoperative computed tomography were enrolled.
        • Full-Text
        • PDF
        Open Access